DERMATA THERAPEUTICS INC (DRMA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.21-1.63%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · DRMA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 7.0 | 4.8 | — | — | — | — | — |
| R&D Expenses | 1.6 | 2.9 | 8.2 | 4.1 | 5.7 | 3.5 | 1.6 |
| Operating Income | (8.6) | (7.8) | (12.5) | (8.0) | (9.7) | (7.9) | (3.2) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | — | 0.0 | 0.2 |
| Interest & Investment Income | 0.2 | 0.2 | — | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (8.4) | (7.6) | (12.3) | (7.8) | (9.6) | (7.9) | (3.2) |
| Per Share | |||||||
| Basic EPS | (2.08) | (8.16) | (8.03) | (39.99) | (13.92) | (2.43) | (1.69) |
| Diluted EPS | (2.08) | (8.16) | (8.03) | (39.99) | — | — | — |
| Basic Weighted Avg Shares | 4.0 | 0.9 | — | — | — | 4.3 | 1.9 |
| Diluted Weighted Avg Shares | 4.0 | 0.9 | 1.5 | 0.2 | — | — | — |
| Supplemental | |||||||
| EBITDA | — | — | — | — | — | (7.9) | (3.2) |
| EBIT | (8.6) | (7.8) | (12.5) | (8.0) | (9.7) | (7.9) | (3.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.